Literature DB >> 24009397

Gut microbiota from twins discordant for obesity modulate metabolism in mice.

Vanessa K Ridaura1, Jeremiah J Faith, Federico E Rey, Jiye Cheng, Alexis E Duncan, Andrew L Kau, Nicholas W Griffin, Vincent Lombard, Bernard Henrissat, James R Bain, Michael J Muehlbauer, Olga Ilkayeva, Clay F Semenkovich, Katsuhiko Funai, David K Hayashi, Barbara J Lyle, Margaret C Martini, Luke K Ursell, Jose C Clemente, William Van Treuren, William A Walters, Rob Knight, Christopher B Newgard, Andrew C Heath, Jeffrey I Gordon.   

Abstract

The role of specific gut microbes in shaping body composition remains unclear. We transplanted fecal microbiota from adult female twin pairs discordant for obesity into germ-free mice fed low-fat mouse chow, as well as diets representing different levels of saturated fat and fruit and vegetable consumption typical of the U.S. diet. Increased total body and fat mass, as well as obesity-associated metabolic phenotypes, were transmissible with uncultured fecal communities and with their corresponding fecal bacterial culture collections. Cohousing mice harboring an obese twin's microbiota (Ob) with mice containing the lean co-twin's microbiota (Ln) prevented the development of increased body mass and obesity-associated metabolic phenotypes in Ob cage mates. Rescue correlated with invasion of specific members of Bacteroidetes from the Ln microbiota into Ob microbiota and was diet-dependent. These findings reveal transmissible, rapid, and modifiable effects of diet-by-microbiota interactions.

Entities:  

Mesh:

Year:  2013        PMID: 24009397      PMCID: PMC3829625          DOI: 10.1126/science.1241214

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  74 in total

1.  Phylogenetic clustering and overdispersion in bacterial communities.

Authors:  M Claire Horner-Devine; Brendan J M Bohannan
Journal:  Ecology       Date:  2006-07       Impact factor: 5.499

2.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

3.  The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins.

Authors:  Nathan P McNulty; Tanya Yatsunenko; Ansel Hsiao; Jeremiah J Faith; Brian D Muegge; Andrew L Goodman; Bernard Henrissat; Raish Oozeer; Stéphanie Cools-Portier; Guillaume Gobert; Christian Chervaux; Dan Knights; Catherine A Lozupone; Rob Knight; Alexis E Duncan; James R Bain; Michael J Muehlbauer; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2011-10-26       Impact factor: 17.956

4.  Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease.

Authors:  Sharon Greenblum; Peter J Turnbaugh; Elhanan Borenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

5.  The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

Authors:  Fadila Benhamed; Pierre-Damien Denechaud; Maud Lemoine; Céline Robichon; Marthe Moldes; Justine Bertrand-Michel; Vlad Ratziu; Lawrence Serfaty; Chantal Housset; Jacqueline Capeau; Jean Girard; Hervé Guillou; Catherine Postic
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

Review 6.  Direct sequencing of the human microbiome readily reveals community differences.

Authors:  Justin Kuczynski; Elizabeth K Costello; Diana R Nemergut; Jesse Zaneveld; Christian L Lauber; Dan Knights; Omry Koren; Noah Fierer; Scott T Kelley; Ruth E Ley; Jeffrey I Gordon; Rob Knight
Journal:  Genome Biol       Date:  2010-05-05       Impact factor: 13.583

7.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

8.  Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.

Authors:  June Zhou; Roy J Martin; Richard T Tulley; Anne M Raggio; Kathleen L McCutcheon; Li Shen; Samuel Colby Danna; Sasmita Tripathy; Maren Hegsted; Michael J Keenan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-16       Impact factor: 4.310

9.  Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

Authors:  Hua V Lin; Andrea Frassetto; Edward J Kowalik; Andrea R Nawrocki; Mofei M Lu; Jennifer R Kosinski; James A Hubert; Daphne Szeto; Xiaorui Yao; Gail Forrest; Donald J Marsh
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

10.  Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome.

Authors:  Margaret L Zupancic; Brandi L Cantarel; Zhenqiu Liu; Elliott F Drabek; Kathleen A Ryan; Shana Cirimotich; Cheron Jones; Rob Knight; William A Walters; Daniel Knights; Emmanuel F Mongodin; Richard B Horenstein; Braxton D Mitchell; Nanette Steinle; Soren Snitker; Alan R Shuldiner; Claire M Fraser
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more
  1270 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 3.  The CF gastrointestinal microbiome: Structure and clinical impact.

Authors:  Geraint B Rogers; Michael R Narkewicz; Lucas R Hoffman
Journal:  Pediatr Pulmonol       Date:  2016-10

4.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

Review 5.  Microbiota and metabolic diseases.

Authors:  Alessia Pascale; Nicoletta Marchesi; Cristina Marelli; Adriana Coppola; Livio Luzi; Stefano Govoni; Andrea Giustina; Carmine Gazzaruso
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

Review 6.  Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy.

Authors:  W L Lowe; J Karban
Journal:  Diabet Med       Date:  2014-03       Impact factor: 4.359

7.  Ingestion of bacterial lipopolysaccharide inhibits peripheral taste responses to sucrose in mice.

Authors:  X Zhu; L He; L P McCluskey
Journal:  Neuroscience       Date:  2013-11-09       Impact factor: 3.590

Review 8.  [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].

Authors:  S C Bischoff
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

Review 9.  Gut microbiome, gut function, and probiotics: Implications for health.

Authors:  Neerja Hajela; B S Ramakrishna; G Balakrish Nair; Philip Abraham; Sarath Gopalan; Nirmal K Ganguly
Journal:  Indian J Gastroenterol       Date:  2015-04-29

Review 10.  Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk.

Authors:  Susan A Joyce; Fergus Shanahan; Colin Hill; Cormac G M Gahan
Journal:  Gut Microbes       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.